[Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease]

C Y Shan1, Q Q Zhang2, Y Xiao3

  • 1Department of Pediatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China (Shan Chengyan is working on the Department of pediatrics, Yantai Yuhuangding Hospital, Yan tai 264000, China).

Insights

Children with inflammatory bowel disease (IBD) frequently develop extraintestinal manifestations (EIMs), particularly Crohn's disease (CD). Key risk factors for EIMs include CD, perianal disease, and younger age at diagnosis.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Epidemiology

Background:

  • Inflammatory Bowel Disease (IBD) encompasses Crohn's disease (CD) and ulcerative colitis (UC), affecting children with significant extraintestinal manifestations (EIMs).
  • Understanding the incidence and risk factors of EIMs in pediatric IBD is crucial for timely diagnosis and management.

Purpose of the Study:

  • To determine the incidence of EIMs in children diagnosed with IBD.
  • To identify the specific risk factors associated with the development of EIMs in this pediatric population.

Main Methods:

  • A retrospective analysis of 161 pediatric IBD patients (CD and UC) treated between 2012 and 2017.
  • Logistic regression models were employed to analyze potential risk factors, including IBD phenotype, disease activity, and demographic data.

Main Results:

  • Over half (54.7%) of pediatric IBD patients experienced EIMs, with immune-mediated conditions and growth retardation being most prevalent.
  • Crohn's disease (CD), perianal disease, younger age at diagnosis (<6 years), and moderate-to-severe disease activity were identified as significant risk factors for EIMs.

Conclusions:

  • Pediatric IBD patients exhibit a high incidence of EIMs, more frequently observed in CD than UC.
  • Early identification of risk factors like CD, perianal disease, and disease severity is essential for proactive management of EIMs in children.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
971
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
908
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
458
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

DNBS/TNBS induced colitis offers an alternative and inexpensive method to study the pathobiology of inflammatory bowel disease. The protocol discussed in this paper outlines the successful application of DNBS to induce colitis in mice and rats and allows one to thoroughly study host-mediated intestinal...
48.6K
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease08:27

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Dynamic adhesion of immune cells to the vessel wall is a prerequisite for gut homing. Here, we present a protocol for a functional in vitro assay for the impact analysis of anti-integrin antibodies, chemokines or other factors on the dynamic cell adhesion of human cells using addressin-coated...
8.1K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
532